Skip to main content

Quitting smoking after lung cancer diagnosis improves survival outcomes

Smoking cessation_illustration

Smokers who quit after receiving a diagnosis of early-stage non-small-cell lung cancer significantly improve their likelihood of survival relative to those who continue smoking, shows a large prospective cohort study.


Trial results do not support canakinumab for COVID-19

Patient receiving IV drugs in hospital bed

Treatment with the IL-1β inhibitor canakinumab does not improve the likelihood of survival without invasive mechanical ventilation among hospitalized patients with severe COVID-19 and systemic hyperinflammation, suggest findings from the CAN-COVID trial.

Headlines from across medwireNews

30-07-2021 | Oncology | News | Article

FDA recommends pembrolizumab for high-risk, early-stage TNBC

Read more on this decision here

30-07-2021 | Rheumatology | News | Article

Baricitinib monotherapy gains FDA authorization for COVID-19

Click through for more information on this update

30-07-2021 | Diabetes | News | Article

SGLT2 inhibitors linked to lower mortality rate than sulfonylureas in clinical practice

Use of SGLT2 inhibitors rather than sulfonylureas as an addition to metformin therapy may be associated with a reduced mortality risk for people with type 2 diabetes, suggest real-world study findings.

30-07-2021 | Oncology | News | Article

No survival benefit with second-line ipilimumab plus nivolumab in advanced squamous NSCLC

The addition of ipilimumab to nivolumab does not improve the survival outcomes of patients with advanced squamous non-small-cell cancer who have previously received chemotherapy, shows the phase 3 LUNG-MAP S1400I trial.

29-07-2021 | Rheumatology | News | Article

Excess GCA deaths mainly occur early in disease course

People with giant cell arteritis have an elevated risk for all-cause mortality relative to the general population, particularly within the first year following diagnosis, researchers report.

29-07-2021 | Diabetes | News | Article

Insulin resistance associated with heart failure, death risk in early type 2 diabetes

Study results suggest that individuals with type 2 diabetes and elevated insulin resistance are at greater risk for heart failure or death than those with greater insulin sensitivity.

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make your preferred medical news resource.

Meet the team

Image Credits